Literature DB >> 24072923

Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area.

Christina Bocklisch1, Vincent Pascoli, Jovi C Y Wong, David R C House, Cédric Yvon, Mathias de Roo, Kelly R Tan, Christian Lüscher.   

Abstract

Drug-evoked synaptic plasticity in the mesolimbic system reshapes circuit function and drives drug-adaptive behavior. Much research has focused on excitatory transmission in the ventral tegmental area (VTA) and the nucleus accumbens (NAc). How drug-evoked synaptic plasticity of inhibitory transmission affects circuit adaptations remains unknown. We found that medium spiny neurons expressing dopamine (DA) receptor type 1 (D1R-MSNs) of the NAc project to the VTA, strongly preferring the GABA neurons of the VTA. Repeated in vivo exposure to cocaine evoked synaptic potentiation at this synapse, occluding homosynaptic inhibitory long-term potentiation. The activity of the VTA GABA neurons was thus reduced and DA neurons were disinhibited. Cocaine-evoked potentiation of GABA release from D1R-MSNs affected drug-adaptive behavior, which identifies these neurons as a promising target for novel addiction treatments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072923     DOI: 10.1126/science.1237059

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

Review 1.  Contemporary approaches to neural circuit manipulation and mapping: focus on reward and addiction.

Authors:  Benjamin T Saunders; Jocelyn M Richard; Patricia H Janak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

2.  Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking.

Authors:  Thibaut R Pardo-Garcia; Constanza Garcia-Keller; Tiffany Penaloza; Christopher T Richie; James Pickel; Bruce T Hope; Brandon K Harvey; Peter W Kalivas; Jasper A Heinsbroek
Journal:  J Neurosci       Date:  2019-01-08       Impact factor: 6.167

3.  Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.

Authors:  Aya Matsui; Brooke C Jarvie; Brooks G Robinson; Shane T Hentges; John T Williams
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

Review 4.  Long-Term Plasticity of Neurotransmitter Release: Emerging Mechanisms and Contributions to Brain Function and Disease.

Authors:  Hannah R Monday; Thomas J Younts; Pablo E Castillo
Journal:  Annu Rev Neurosci       Date:  2018-04-25       Impact factor: 12.449

5.  Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.

Authors:  Lesley A McCollum; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

6.  Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists.

Authors:  Michael Wolter; Thomas Lapointe; Brett Melanson; Nana Baidoo; Travis Francis; Boyer D Winters; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2021-06-26       Impact factor: 4.530

7.  Sorting nexin 27 regulation of G protein-gated inwardly rectifying K⁺ channels attenuates in vivo cocaine response.

Authors:  Michaelanne B Munoz; Paul A Slesinger
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

Review 8.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

Review 9.  Dopamine Prediction Errors in Reward Learning and Addiction: From Theory to Neural Circuitry.

Authors:  Ronald Keiflin; Patricia H Janak
Journal:  Neuron       Date:  2015-10-21       Impact factor: 17.173

Review 10.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.